ELVN · Insider trading · 13F holders · Congress trades
Enliven Therapeutics, Inc. (ELVN)
Who is buying and selling ELVN: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 38
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $11.8M
- Congress trades, 12 months
- 0
ELVN at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 ELVN insiders filed 8 sales worth $11.8M on SEC Form 4, and no open-market purchases; 7 of the sales were pre-planned under Rule 10b5-1.
- 38 13F filers hold ELVN among their 50 largest positions, worth $1.9B combined, including Robert Pohly and Julian and Felix Baker. The biggest bets by portfolio weight are Commodore Capital LP (9.9%), Orbimed Advisors LLC (6.5%) and Fairmount Funds Management LLC (6.2%). In their latest 13Fs, 5 managers opened a new position and 11 added to one.
- No member of Congress has disclosed a trade in ELVN.
- ELVN last closed at $45.08 on Oct 29, 2026.
ELVN insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 ELVN insiders filed 8 sales worth $11.8M on SEC Form 4, and no open-market purchases; 7 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale10b5-1 | 6,018 | $38.48 | $232K | SEC |
| Oct 21, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sale10b5-1 | 5,000 | $38.47 | $192K | SEC |
| Oct 5, 2026 | Garland J. Scott | Director | Sale | 13,000 | $46.67 | $607K | SEC |
| Sep 21, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale10b5-1 | 6,018 | $50.35 | $303K | SEC |
| Sep 21, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sale10b5-1 | 5,000 | $50.35 | $252K | SEC |
| Aug 19, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale10b5-1 | 6,018 | $58.58 | $353K | SEC |
| Aug 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sale10b5-1 | 5,000 | $58.59 | $293K | SEC |
| Aug 6, 2026 | Derynck Mika K | Director | Sale10b5-1 | 158,795 | $60.21 | $9.6M | SEC |
Who owns ELVN? Hedge funds and superinvestors
38 13F filers hold ELVN among their 50 largest positions, worth $1.9B combined, including Robert Pohly and Julian and Felix Baker. The biggest bets by portfolio weight are Commodore Capital LP (9.9%), Orbimed Advisors LLC (6.5%) and Fairmount Funds Management LLC (6.2%). In their latest 13Fs, 5 managers opened a new position and 11 added to one.
Superinvestors holding ELVN: Robert Pohly 0.8% · Julian and Felix Baker 0.2%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Orbimed Advisors LLCHedge fund | 6.5% | $343.9M | 6,776,632 | -14.9% shares | Q2 2026 |
| Polar Capital Holdings PlcHedge fund | 0.9% | $326.4M | 6,430,636 | +26.9% shares | Q2 2026 |
| Vestal Point Capital, LPHedge fund | 4.7% | $203.0M | 4,000,000 | +23.1% shares | Q2 2026 |
| Commodore Capital LPHedge fund | 9.9% | $166.2M | 3,275,000 | +0.0% shares | Q2 2026 |
| Fairmount Funds Management LLCHedge fund | 6.2% | $94.2M | 1,855,644 | +0.0% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 1.8% | $90.1M | 1,774,411 | +137.8% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 1.6% | $75.6M | 1,490,000 | -35.8% shares | Q2 2026 |
| First Light Asset Management, LLCHedge fund | 4.2% | $69.1M | 1,360,750 | +574.1% shares | Q2 2026 |
| Novo Holdings A/sInvestment manager | 2.9% | $50.8M | 1,000,000 | -21.9% shares | Q2 2026 |
| First Turn Management, LLCInstitutional asset manager | 5.2% | $48.4M | 954,360 | +53.0% shares | Q2 2026 |
| Robert PohlyHedge fund | 0.8% | $46.3M | 912,637 | — | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.2% | $45.9M | 905,191 | +0.0% shares | Q2 2026 |
| Tri Locum Partners LPHedge fund | 5.4% | $44.0M | 866,716 | New | Q2 2026 |
| Avidity Partners Management LPHedge fund | 4.5% | $27.9M | 550,000 | +37.5% shares | Q2 2026 |
| Venrock Adviser, LLCHedge fund | 0.8% | $26.7M | 526,331 | -69.5% shares | Q2 2026 |
| Affinity Asset Advisors, LLCHedge fund | 1.3% | $25.4M | 500,000 | -14.8% shares | Q2 2026 |
| Silverarc Capital Management, LLCHedge fund | 2.8% | $24.8M | 489,382 | — | Q2 2026 |
| Logos Global Management LPHedge fund | 1.0% | $23.6M | 465,000 | -13.9% shares | Q2 2026 |
| Rock Springs Capital Management LPHedge fund | 1.2% | $23.6M | 464,625 | -43.8% shares | Q2 2026 |
| Nicholas Investment Partners, LPInvestment manager | 1.3% | $19.9M | 391,529 | — | Q2 2026 |
| ADAR1 Capital Management, LLCHedge fund | 0.9% | $19.7M | 387,718 | +17.7% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 3.1% | $18.5M | 365,386 | +122.8% shares | Q2 2026 |
| Stempoint Capital LPHedge fund | 3.0% | $17.6M | 346,914 | -4.5% shares | Q2 2026 |
| Spruce Street Capital LPHedge fund | 3.3% | $16.7M | 329,006 | +0.0% shares | Q2 2026 |
| Patient Square Capital LPHedge fund | 1.7% | $10.8M | 212,500 | +6.3% shares | Q2 2026 |
| Squadron Capital Management LLCHedge fund | 2.8% | $8.1M | 160,000 | New | Q2 2026 |
| Cormorant Asset Management, LPHedge fund | 0.4% | $7.6M | 150,000 | New | Q2 2026 |
| HighVista Strategies LLCHedge fund | 1.6% | $7.0M | 137,866 | +88.6% shares | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 1.1% | $6.4M | 126,541 | — | Q2 2026 |
| Sphera Funds Management Ltd.Hedge fund | 0.8% | $5.7M | 112,765 | -26.4% shares | Q2 2026 |
The 30 largest of 38 positions, by value. Each manager counts with its latest 13F (Q2 2026: 38). Screen ELVN in the grand portfolio →
ELVN stock trades by members of Congress
No member of Congress has disclosed a trade in ELVN.
ELVN questions and answers
Are insiders buying ELVN stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 ELVN insiders filed 8 sales worth $11.8M on SEC Form 4, and no open-market purchases; 7 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own ELVN?
38 13F filers hold ELVN among their 50 largest positions, worth $1.9B combined, including Robert Pohly and Julian and Felix Baker. The biggest bets by portfolio weight are Commodore Capital LP (9.9%), Orbimed Advisors LLC (6.5%) and Fairmount Funds Management LLC (6.2%). In their latest 13Fs, 5 managers opened a new position and 11 added to one.
Has Congress traded ELVN?
No member of Congress has disclosed a trade in ELVN.
Who is the largest holder of ELVN?
Among 13F filers, Orbimed Advisors LLC reports the largest ELVN position, $343.9M (6,776,632 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Commodore Capital LP's: 9.9% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.